nos.nl
🌐 85% Global Worthiness
McKinsey Pays $650 Million to Settle Opioid Marketing Case
McKinsey & Company will pay $650 million to settle US claims that it helped market opioid painkillers, including advising Purdue Pharma on boosting OxyContin sales; a former McKinsey partner will plead guilty next month, and the firm is prohibited from opioid marketing for five years.
McKinsey Pays $650 Million to Settle Opioid Marketing Case
McKinsey & Company will pay $650 million to settle US claims that it helped market opioid painkillers, including advising Purdue Pharma on boosting OxyContin sales; a former McKinsey partner will plead guilty next month, and the firm is prohibited from opioid marketing for five years.
Progress
36% Bias Score
Good Health and Well-being